Follow the Guard Therapeutics International AB (publ) share price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Guard Therapeutics International AB (publ) has recorded 1 reports. Market capitalisation: €28.2m. The latest transaction was filed on 6 August 2026 (Purchase). Among the most active insiders: Alexander Oker-Blom. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Guard Therapeutics International AB (publ) is a biopharmaceutical company focused on developing treatments for kidney diseases. It is listed on the Stockholm Stock Exchange (XSTO).